Steve Krognes
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Steve Krognes
Steve Krognes is recorded as Board Member at Pliant Therapeutics, Inc. (PLRX). Pliant Therapeutics, Inc. reported in an 8-K filed June 14, 2024 that Steve Krognes was appointed Chairperson of the Audit Committee, effective June 13, 2024. Pliant Therapeutics, Inc. reported in an 8-K filed June 14, 2024 that Steve Krognes was appointed Class III director, effective June 13, 2024.
“In addition, effective as of the Effective Date, the Board appointed Mr. Krognes to serve as Chairperson of the Audit Committee of the Board (the "Audit Committee") upon the recommendation of the Nominating and Governance Committee.”
“On the Effective Date, the Board appointed, upon the recommendation of the Nominating and Corporate Governance Committee of the Board (the "Nominating and Governance Committee"), Steve Krognes to fill the Class III vacancy on the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Pliant Therapeutics, Inc. (PLRX)
SEC 8-K
Current2024-06-13–present
-
Current
2024-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Pliant Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Bernard Coulie CEO, Board Member
- Keith Cummings CFO, Board Member
- Minnie Kuo COO, Board Member
- Mike Ouimette General Counsel
- Dr. Katharine Knobil Board Member
- Flavia Borellini, Ph.D. Board Member
- Gayle Crowell Board Member
- Lily Cheung Board Member
- Robert Iannone, M.D., M.S.C.E. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.